Enhanced protective efficacy of a tuberculosis DNA vaccine by adsorption onto cationic PLG microparticles. (Q51631551)

8 April 2018

title

Enhanced protective efficacy of a tuberculosis DNA vaccine by adsorption onto cationic PLG microparticles. (English)

1 reference

8 April 2018

1 reference

10

1 reference

8 April 2018

Hans-Joachim Mollenkopf

object named as

Hans-Joachim Mollenkopf

1

0 references

author name string

Guido Dietrich

2

1 reference

8 April 2018

Joachim Fensterle

3

1 reference

8 April 2018

Leander Grode

4

1 reference

8 April 2018

Klaus-Dieter Diehl

5

1 reference

8 April 2018

Bernhard Knapp

6

1 reference

8 April 2018

Manmohan Singh

7

1 reference

8 April 2018

Derek T O'Hagan

8

1 reference

8 April 2018

Jeffrey B Ulmer

9

1 reference

8 April 2018

language of work or name

English

0 references

publication date

1 July 2004

1 reference

8 April 2018

published in

Vaccine

1 reference

8 April 2018

volume

22

1 reference

8 April 2018

issue

21-22

1 reference

8 April 2018

page(s)

2690-2695

1 reference

8 April 2018

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

1 reference

Direct gene transfer into nonhuman primate myofibers in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Genetic immunization is a simple method for eliciting an immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Intranasal immunization with mumps virus DNA vaccine delivered by influenza virosomes elicits mucosal and systemic immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Tumour-associated antigen (TAA)-specific cytotoxic T cell (CTL) response in vitro and in a mouse model, induced by TAA-plasmids delivered by influenza virosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Stabilization of poly-L-lysine/DNA polyplexes for in vivo gene delivery to the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Oral somatic transgene vaccination using attenuated S. typhimurium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

DNA vaccines for bacterial infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Vaccination against tuberculosis by DNA injection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Expression and immunogenicity of Mycobacterium tuberculosis antigen 85 by DNA vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Cationic microparticles: A potent delivery system for DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Improved tuberculosis DNA vaccines by formulation in cationic lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Induction of cellular immunity to a mycobacterial antigen adsorbed on lamellar particles of lactide polymers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Plasmid DNA encoding human carcinoembryonic antigen (CEA) adsorbed onto cationic microparticles induces protective immunity against colon cancer in CEA-transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.05.005

10.1016/J.VACCINE.2004.05.005

7 January 2021

Identifiers

DOI

1 reference

8 April 2018

PubMed ID

15309815

1 reference

8 April 2018